DNAVSGRAL• 7 Days (Normalized)
DNA vs GRAL (Ginkgo Bioworks Holdings Inc. vs GRAIL Inc.)
Showing Closing Date Range from Sep 23 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GRAL Performance $136.57
+25.85%
GRAIL Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
-25.85 pts
GRAL outperforming by 25.85 percentage points
DNAGRAL
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GRAL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | DNA Price | DNA Gain (%) | GRAL Price | GRAL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $136.57 | +25.85% | - | |
| Sep 28, 2026 | $10.46 | +21.91% | $132.63 | +22.22% | -0.31% |
| Sep 25, 2026 | $10.66 | +24.24% | $126.89 | +16.93% | +7.31% |
| Sep 24, 2026 | $10.25 | +19.46% | $125.21 | +15.38% | +4.08% |
| Sep 23, 2026 | $8.58 | +0.00% | $108.52 | +0.00% | +0.00% |